Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy. Clinics, [S. l.], v. 73, n. Suppl. 1, p. e792s, 2019. DOI: 10.6061/clinics/2018/e792s. Disponível em: https://revistas.usp.br/clinics/article/view/154887.. Acesso em: 3 may. 2024.